Expression of lncRNA-ROR is increased in several cancer types and serves as a prognosis marker including colorectal cancer [95,96,97], and silencing its expression in CRC cells enhances sensitivity to radiotherapy via negative regulation of the p53/miR-145 axis. The gene discussed is TP53; the disease is cancer.